Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies. | Paediatr Drugs | 2022 | 36028610 | PubTator, text mining | PubMed |
| Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. | Int J Mol Sci | 2022 | 36012138 | PubTator, text mining | PubMed |
| When a Synonymous Variant Is Nonsynonymous. | Genes (Basel) | 2022 | 36011397 | PubTator, text mining | PubMed |
| RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction. | Cells | 2022 | 36010571 | PubTator, text mining | PubMed |
| Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies. | Children (Basel) | 2022 | 36010097 | PubTator, text mining | PubMed |
| Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe. | Front Pharmacol | 2022 | 35991868 | PubTator, text mining | PubMed |
| A Frameshift RBM10 Variant Associated With TARP Syndrome. | Front Genet | 2022 | 35991558 | PubTator, text mining | PubMed |
| Suppression of the necroptotic cell death pathways improves survival in Smn 2B/- mice. | Front Cell Neurosci | 2022 | 35990890 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma. | Signal Transduct Target Ther | 2022 | 35989380 | PubTator, text mining | PubMed |
| Cost-effectiveness analysis of gene-based therapies for patients with spinal muscular atrophy type I in Australia. | J Neurol | 2022 | 35980467 | PubTator, text mining | PubMed |
| Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy. | Cell Rep Med | 2022 | 35977471 | PubTator, text mining | PubMed |
| Gene therapy in neuromuscular disorders. | Arq Neuropsiquiatr | 2022 | 35976325 | PubTator, text mining | PubMed |
| Approved gene therapies in Australia: coming to a store near you. | Intern Med J | 2022 | 35973959 | PubTator, text mining | PubMed |
| Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? | Int J Mol Sci | 2022 | 35955433 | PubTator, text mining | PubMed |
| Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G>C Variant in SMN2 | Int J Mol Sci | 2022 | 35955418 | PubTator, text mining | PubMed |
| Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy. | Ann Clin Transl Neurol | 2022 | 35951535 | PubTator, text mining | PubMed |
| Newborn screening for spinal muscular atrophy in Japan: One year of experience. | Mol Genet Metab Rep | 2022 | 35942129 | PubTator, text mining | PubMed |
| Targeting RNA structures with small molecules. | Nat Rev Drug Discov | 2022 | 35941229 | PubTator, text mining | PubMed |
| Genetic Spectrum of Inherited Neuropathies in India. | Ann Indian Acad Neurol | 2022 | 35936615 | PubTator, text mining | PubMed |
| Artificial primary-miRNAs as a platform for simultaneous delivery of siRNA and antisense oligonucleotide for multimodal gene regulation. | J Control Release | 2022 | 35931211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=44